Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studiesChris Twelves(St James's University Hospital), Ahmad Awada(Institut Jules Bordet)Breast Cancer Research and TreatmentNovember 8, 201410.1007/s10549-014-3144-yCited by 214SaveCiteExport RISWatch citationsRelated PapersSupplementary materials and methods from On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors|Unknown|2023|0